YI · 111, Inc.
$3.56
-0.39 (-9.87%)
At close · Jul 29
Market Cap
$33.87M
Shares
8.80M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
12.56B
-12.8%
FY2025
Net Income
-22.52M
-8.4%
FY2025
Diluted EPS
-0.38
0%
FY2025
Operating Cash Flow
119.14M
-54.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| CNY | 12.56B | 14.4B | 14.95B | 13.52B | 12.43B | 8.2B | 3.95B | 1.79B | 959.49M | 873.84M |
| CNY | 11.83B | 13.57B | 14.1B | 12.68B | 11.8B | 7.84B | 3.79B | 73.93M | 55.88M | — |
| CNY | 723.41M | 829.23M | 848.98M | 839.98M | 621.1M | 365.83M | 165.18M | 104.27M | 80.5M | 74.13M |
| CNY | 258.64M | 313.9M | 448.39M | 457.88M | 513.15M | 399.61M | 340.56M | 260.04M | 190.07M | 252.83M |
| CNY | 69.46M | 70.91M | 224.2M | 205.62M | 206.98M | 128.23M | 123.5M | 98.76M | 53.43M | 60.84M |
| CNY | 568K | 815K | 1.01M | 1.74M | 1.71M | 1.79M | — | 623K | 617K | 698K |
| CNY | 11.84M | 16.97M | 21.78M | 40.82M | 27.22M | 14.02M | 11.67M | 11.27M | 14.82M | 12.06M |
| CNY | 12.56B | 14.4B | 15.3B | 13.89B | 13.07B | 8.68B | 4.45B | 2.19B | 1.21B | 1.24B |
| CNY | -2.38M | 2.11M | -350.1M | -371M | -642.14M | -473.31M | -493.51M | -400.38M | -254.02M | -364.28M |
| CNY | 35.57M | 28.33M | 20.14M | 13.44M | 5.49M | 8.82M | 3.62M | — | 55K | 751K |
| CNY | 3.89M | 7.04M | 8.83M | 8.12M | 9.78M | 6.31M | 4.8M | 4.35M | 4.01M | 2.31M |
| CNY | 11.08M | -595K | 7.61M | 8.13M | 14.89M | 3.16M | 834K | 11.53M | 4.23M | -3.35M |
| CNY | -22.5M | -20.68M | -353.18M | -376.07M | -621.03M | -467.11M | -501.83M | -382.03M | -249.33M | -363.45M |
| CNY | 13K | 96K | 251K | 0 | 0 | 0 | 0 | 8000 | — | — |
| CNY | -22.52M | -20.78M | -353.43M | -376.07M | -621.03M | -467.11M | -501.83M | -382.04M | -249.33M | -363.45M |
| CNY | -4.09M | -8.4M | -16.83M | -15.28M | -27.82M | 0 | -2.22M | -1.95M | -747K | -765K |
| CNY | -66.39M | -64.74M | -392.69M | -416.88M | -669.81M | -456.53M | -499.61M | -380.09M | -248.58M | -417.96M |
| CNY | -68.11M | -62.9M | -395.77M | -400.66M | -673.35M | -470.06M | -490.24M | -360.57M | -265.9M | -376.72M |
| CNY/shares | -0.38 | -0.38 | -2.33 | -2.50 | -4.04 | -2.77 | -3.05 | — | — | — |
| CNY/shares | -0.38 | -0.38 | -2.33 | -2.50 | -4.04 | -2.77 | -3.05 | — | — | — |
| shares | 174.03M | 171.84M | 168.61M | 166.63M | 165.87M | 164.79M | 163.67M | 99.45M | 72M | 72M |
| shares | 174.03M | 171.84M | 168.61M | 166.63M | 165.87M | 164.79M | 163.67M | 99.45M | 72M | 72M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2021: $40.86M in buybacks.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (CNY)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Business to Business B2b Business | 12,321,205,000 | 14,123,152,000 | 14,570,766,000 | 13,075,170,000 | 11,839,850,000 | 7,490,449,000 | 3,293,268,000 | 1,061,559,000 |
| Business to Consumer B2c Business | 234,818,000 | 278,097,000 | 377,363,000 | 441,528,000 | 491,855,000 | 666,223,000 | 636,430,000 | 709,585,000 |
By Product & Service (CNY)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Drugs | 11,649,921,000 | 13,398,162,000 | 13,883,055,000 | 12,572,634,000 | 11,681,106,000 | 7,398,433,000 | 3,595,419,000 | 1,490,834,000 |
| Nutritional Supplements | 434,685,000 | 550,464,000 | 631,122,000 | 554,789,000 | 442,497,000 | — | 245,644,000 | 190,425,000 |
| Business to Consumer B2c Business | 223,217,000 | — | — | — | 491,855,000 | 666,223,000 | — | 709,585,000 |
| Medical Supplies and Devices | 152,351,000 | 144,282,000 | 157,504,000 | 164,916,000 | 124,919,000 | — | 50,178,000 | 26,563,000 |
| Mp Service | 56,749,000 | — | — | — | 52,309,000 | 30,533,000 | 17,239,000 | 12,490,000 |
| Service | — | — | — | 113,262,000 | 94,197,000 | — | — | 14,826,000 |
| Service Other | — | 40,973,000 | 35,948,000 | 44,785,000 | 41,888,000 | 15,952,000 | — | 2,336,000 |
| Business to Business B2b Business | — | — | — | — | 11,839,850,000 | — | — | 1,061,559,000 |
| Contact Lenses | — | — | — | — | 38,000 | 3,420,000 | 18,110,000 | 47,295,000 |
| Other Products | — | 201,832,000 | 170,229,000 | — | 83,183,000 | 49,949,000 | 20,347,000 | 16,027,000 |